Literature DB >> 18074229

Effect of high beta-glucan barley on serum cholesterol concentrations and visceral fat area in Japanese men--a randomized, double-blinded, placebo-controlled trial.

Chikako Shimizu1, Makoto Kihara, Seiichiro Aoe, Shigeki Araki, Kazutoshi Ito, Katsuhiro Hayashi, Junji Watari, Yukikuni Sakata, Sachie Ikegami.   

Abstract

This study investigated whether the consumption of a diet in which high-beta-glucan barley replaced rice would reduce the visceral fat area as well as the serum low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) in hypercholesterolemic Japanese men. A randomized, double-blinded, placebo-controlled intervention study was conducted in 44 hypercholesterolemic Japanese men with a body mass index (BMI) >22 kg/m2. The subjects were randomly assigned to groups consuming either rice (placebo group) or a mixture of rice and pearl barley with a high beta-glucan content (test group, 7.0 g beta-glucan per day) for 12 weeks. Blood samples were taken, and CT scan obtained before the trial and every four weeks during the trial. The pearl barley intake significantly reduced serum concentrations of LDL-C (P = 0.041) and TC (P = 0.037) during the trial. Significant differences between the test and placebo groups were found for the visceral fat (P = 0.039), BMI (P = 0.015), and waist circumference (P = 0.011) at the end point. The consumption of pearl barley with a high beta-glucan content reduces not only LDL-C but also visceral fat area.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18074229     DOI: 10.1007/s11130-007-0064-6

Source DB:  PubMed          Journal:  Plant Foods Hum Nutr        ISSN: 0921-9668            Impact factor:   3.921


  7 in total

1.  High-fiber oat cereal compared with wheat cereal consumption favorably alters LDL-cholesterol subclass and particle numbers in middle-aged and older men.

Authors:  Brenda M Davy; Kevin P Davy; Richard C Ho; Stacy D Beske; Linda R Davrath; Christopher L Melby
Journal:  Am J Clin Nutr       Date:  2002-08       Impact factor: 7.045

2.  Low glycemic index carbohydrate foods in the management of hyperlipidemia.

Authors:  D J Jenkins; T M Wolever; J Kalmusky; S Giudici; C Giordano; G S Wong; J N Bird; R Patten; M Hall; G Buckley
Journal:  Am J Clin Nutr       Date:  1985-10       Impact factor: 7.045

Review 3.  Sites and mechanisms for the hypocholesterolemic actions of soluble dietary fiber sources.

Authors:  J A Marlett
Journal:  Adv Exp Med Biol       Date:  1997       Impact factor: 2.622

4.  Effect of boiled barley-rice-feeding in hypercholesterolemic and normolipemic subjects.

Authors:  S Ikegami; M Tomita; S Honda; M Yamaguchi; R Mizukawa; Y Suzuki; K Ishii; S Ohsawa; N Kiyooka; M Higuchi; S Kobayashi
Journal:  Plant Foods Hum Nutr       Date:  1996-06       Impact factor: 3.921

5.  Diets containing barley significantly reduce lipids in mildly hypercholesterolemic men and women.

Authors:  Kay M Behall; Daniel J Scholfield; Judith Hallfrisch
Journal:  Am J Clin Nutr       Date:  2004-11       Impact factor: 7.045

6.  Health claims on functional foods: the Japanese regulations and an international comparison.

Authors:  Toshio Shimizu
Journal:  Nutr Res Rev       Date:  2003-12       Impact factor: 7.800

7.  Oat beta-glucan increases bile acid excretion and a fiber-rich barley fraction increases cholesterol excretion in ileostomy subjects.

Authors:  A Lia; G Hallmans; A S Sandberg; B Sundberg; P Aman; H Andersson
Journal:  Am J Clin Nutr       Date:  1995-12       Impact factor: 7.045

  7 in total
  17 in total

Review 1.  Effects of whole grains on coronary heart disease risk.

Authors:  Kristina A Harris; Penny M Kris-Etherton
Journal:  Curr Atheroscler Rep       Date:  2010-11       Impact factor: 5.113

2.  Integration of β-glucan fibre rich fractions from barley and mushrooms to form healthy extruded snacks.

Authors:  Margaret A Brennan; Emma Derbyshire; Brijesh K Tiwari; Charles S Brennan
Journal:  Plant Foods Hum Nutr       Date:  2013-03       Impact factor: 3.921

Review 3.  A systematic review and meta-analysis of randomized controlled trials of the effect of barley β-glucan on LDL-C, non-HDL-C and apoB for cardiovascular disease risk reductioni-iv.

Authors:  H V T Ho; J L Sievenpiper; A Zurbau; S Blanco Mejia; E Jovanovski; F Au-Yeung; A L Jenkins; V Vuksan
Journal:  Eur J Clin Nutr       Date:  2016-06-08       Impact factor: 4.016

4.  Effect of dietary fiber of "Rihane" barley grains and azoxymethane on serum and liver lipid variables in Wistar rats.

Authors:  Lamia Lahouar; Fatma Ghrairi; Mouldi El Felah; Hichem Ben Salem; Abdel Hedi Miled; Mohamed Hammami; Lotfi Achour
Journal:  J Physiol Biochem       Date:  2010-09-18       Impact factor: 4.158

5.  The effects of barley-derived soluble fiber on serum lipids.

Authors:  Ripple Talati; William L Baker; Mary S Pabilonia; C Michael White; Craig I Coleman
Journal:  Ann Fam Med       Date:  2009 Mar-Apr       Impact factor: 5.166

6.  Insoluble carob fiber rich in polyphenols lowers total and LDL cholesterol in hypercholesterolemic sujects.

Authors:  Baltasar Ruiz-Roso; José C Quintela; Ester de la Fuente; Javier Haya; Lourdes Pérez-Olleros
Journal:  Plant Foods Hum Nutr       Date:  2010-03       Impact factor: 3.921

7.  Behavioral and neuronal biochemical possible effects in experimental induced chronic mild stress in male albino rats under the effect of oral barley administration in comparison to venlafaxine.

Authors:  Inas E Darwish; Hala M Maklad; Iman H Diab
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-05-27

Review 8.  Dietary fibre for the primary prevention of cardiovascular disease.

Authors:  Louise Hartley; Michael D May; Emma Loveman; Jill L Colquitt; Karen Rees
Journal:  Cochrane Database Syst Rev       Date:  2016-01-07

9.  Beta glucan: health benefits in obesity and metabolic syndrome.

Authors:  D El Khoury; C Cuda; B L Luhovyy; G H Anderson
Journal:  J Nutr Metab       Date:  2011-12-11

Review 10.  Beta-glucans in the treatment of diabetes and associated cardiovascular risks.

Authors:  Jiezhong Chen; Kenneth Raymond
Journal:  Vasc Health Risk Manag       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.